Blitz Bureau
NEW DELHI: Commerce Minister Piyush Goyal has invited American companies to leverage India’s unmatched scale and take advantage of the ‘Make in India’ initiative, particularly in high-tech manufacturing and quality production.
Goyal, who began his four-day visit to the US this week, had a discussions with existing and potential US investors, highlighting the avenues for cooperation in various sectors.
According to a Ministry of Commerce and Industry statement, in his meeting with Stephen Schwarzman who is the CEO of top investment firm Blackstone, Goyal took note of the fact that the company has already invested about $50 billion in India and is one of the largest commercial and real estate investors in the country.
Timothy F Geithner, President of Warburg Pincus, also called on Goyal for a one-on-one discussion that covered various areas where there is scope for further improving the ease of doing business.
“Had an engaging meeting with Sanjiv Ahuja, Founder, Chairman, and CEO of the leading global digital infrastructure firm, Tillman Global Holdings,” Goyal posted on X social media platform.
“India’s world-class digital infrastructure offers exciting investment opportunities, including in sustainable data centres. With its skilled talent pool, we are nurturing innovation and enterprise to position India as a leader in green technology and capabilities,” he added.
Goyal also chaired a roundtable discussion with young CEOs and entrepreneurs of Indian origin in New York, organised by the Consulate General of India.
Goyal emphasised the transformative reforms undertaken under the leadership of Prime Minister Narendra Modi, which has propelled India’s remarkable growth over the past decade.
Goyal held one-on-one meetings with several CEOs discussing new areas of collaboration, particularly in advanced manufacturing, pharmaceuticals, robotics, artificial intelligence, and sustainable technologies.
Goyal met Chintu Patel, Co-CEO, and Chirag Patel, President and Co-CEO of Amneal Pharmaceuticals. They explored ways to enhance India’s pharmaceutical ecosystem for high-end RD, including biologics, and improved manufacturing capabilities to establish a robust global supply chain.
A productive meeting was held with Henry R Kravis, Co-Founder and Co-Executive Chairman of Kohlberg Kravis Roberts and Co (KKR).
Goyal highlighted potential investment opportunities in India’s electronics manufacturing, data infrastructure, and logistics sectors. He underscored the consistent economic growth in India over the past decade and the vast consumer market, which present numerous opportunities for strategic investments.
